Clinical Trials Browser

Phase 1/2 × Amyloidosis × 90 days × Clear all

NCT07081646 2026-03-13

ALACRITY

Phase 1/2 Recruiting

Immunoglobulin Light-chain Amyloidosis, Amyloidosis

NCT05145816 2026-02-17

Phase 1/2a Study of Belantamab Mafodotin in Relapsed or Refractory AL Amyloidosis

Phase 1/2 Recruiting

Immunoglobulin Light-chain Amyloidosis, Amyloidosis